Expression of CD10 by B-chronic lymphocytic leukemia cells undergoing apoptosis in vivo and in vitro

Fortunato Morabito, Massimo Mangiola, Davide Rapezzi, Simona Zupo, Bianca Maria Oliva, Anna Maria Ferraris, Mauro Spriano, Edoardo Rossi, Caterina Stelitano, Vincenzo Callea, Giovanna Cutrona, Manlio Ferrarini

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Background and Objectives. B-cell chronic lymphocytic leukemia (B-CLL) is an accumulating disease of slowly proliferating cells. CD10 is not normally expressed on the surface of B-CLL cells. The aim of this study was to ascertain whether B-CLL cells, induced into apoptosis, expressed surface CD10, since a correlation between apoptosis and CD10 expression has been demonstrated. Design and Methods. Peripheral blood cells from 31 untreated B-CLL patients were induced into apoptosis by etoposide, fludarabine or Gaμ-Ab treatment and tested for CD10 expression by flow cytometry. Normal CD5+ B cells were also induced into apoptosis and tested for CD10 expression. Results. CD10 positive cells were absent in B-CLL cell suspensions, but were detected following in vitro culture, and their appearance paralleled that of apoptotic cells. Treatment with etoposide, fludarabine or Gaμ-Ab enhanced both apoptosis and CD10 expression. Inhibition of apoptosis by VAD-fmk or Gaδ-Ab prevented CD10 expression. Cell separation tests following induction of apoptosis demonstrated that CD10+ cells were apoptotic. CD10+ cells were observed in the peripheral blood of two patients within a few hours following fludarabine infusion. In another patient, who failed to respond, no CD10+ cells were seen. Expression of CD10 was observed also in normal CD5+ B cells when these were induced into apoptosis. Interpretation and Conclusions. This study demonstrates that B-CLL cells, as well as normal CD5+ B cells, become CD10+ following apoptosis induction in vitro. Some of the data obtained also suggest a use for CD10 to monitor apoptosis of B-CLL in a clinical setting.

Original languageEnglish
Pages (from-to)864-873
Number of pages10
JournalHaematologica
Volume88
Issue number8
Publication statusPublished - Aug 1 2003

Fingerprint

B-Cell Chronic Lymphocytic Leukemia
Apoptosis
B-Lymphocytes
Etoposide
In Vitro Techniques
Cell Separation
Blood Cells
Suspensions
Flow Cytometry

Keywords

  • Apoptosis
  • Chronic lymphocytic leukemia
  • Fludarabine
  • Neutral endopeptidase

ASJC Scopus subject areas

  • Hematology

Cite this

Morabito, F., Mangiola, M., Rapezzi, D., Zupo, S., Oliva, B. M., Ferraris, A. M., ... Ferrarini, M. (2003). Expression of CD10 by B-chronic lymphocytic leukemia cells undergoing apoptosis in vivo and in vitro. Haematologica, 88(8), 864-873.

Expression of CD10 by B-chronic lymphocytic leukemia cells undergoing apoptosis in vivo and in vitro. / Morabito, Fortunato; Mangiola, Massimo; Rapezzi, Davide; Zupo, Simona; Oliva, Bianca Maria; Ferraris, Anna Maria; Spriano, Mauro; Rossi, Edoardo; Stelitano, Caterina; Callea, Vincenzo; Cutrona, Giovanna; Ferrarini, Manlio.

In: Haematologica, Vol. 88, No. 8, 01.08.2003, p. 864-873.

Research output: Contribution to journalArticle

Morabito, F, Mangiola, M, Rapezzi, D, Zupo, S, Oliva, BM, Ferraris, AM, Spriano, M, Rossi, E, Stelitano, C, Callea, V, Cutrona, G & Ferrarini, M 2003, 'Expression of CD10 by B-chronic lymphocytic leukemia cells undergoing apoptosis in vivo and in vitro', Haematologica, vol. 88, no. 8, pp. 864-873.
Morabito F, Mangiola M, Rapezzi D, Zupo S, Oliva BM, Ferraris AM et al. Expression of CD10 by B-chronic lymphocytic leukemia cells undergoing apoptosis in vivo and in vitro. Haematologica. 2003 Aug 1;88(8):864-873.
Morabito, Fortunato ; Mangiola, Massimo ; Rapezzi, Davide ; Zupo, Simona ; Oliva, Bianca Maria ; Ferraris, Anna Maria ; Spriano, Mauro ; Rossi, Edoardo ; Stelitano, Caterina ; Callea, Vincenzo ; Cutrona, Giovanna ; Ferrarini, Manlio. / Expression of CD10 by B-chronic lymphocytic leukemia cells undergoing apoptosis in vivo and in vitro. In: Haematologica. 2003 ; Vol. 88, No. 8. pp. 864-873.
@article{bedd9f31cf3c4602b38734023b527ffc,
title = "Expression of CD10 by B-chronic lymphocytic leukemia cells undergoing apoptosis in vivo and in vitro",
abstract = "Background and Objectives. B-cell chronic lymphocytic leukemia (B-CLL) is an accumulating disease of slowly proliferating cells. CD10 is not normally expressed on the surface of B-CLL cells. The aim of this study was to ascertain whether B-CLL cells, induced into apoptosis, expressed surface CD10, since a correlation between apoptosis and CD10 expression has been demonstrated. Design and Methods. Peripheral blood cells from 31 untreated B-CLL patients were induced into apoptosis by etoposide, fludarabine or Gaμ-Ab treatment and tested for CD10 expression by flow cytometry. Normal CD5+ B cells were also induced into apoptosis and tested for CD10 expression. Results. CD10 positive cells were absent in B-CLL cell suspensions, but were detected following in vitro culture, and their appearance paralleled that of apoptotic cells. Treatment with etoposide, fludarabine or Gaμ-Ab enhanced both apoptosis and CD10 expression. Inhibition of apoptosis by VAD-fmk or Gaδ-Ab prevented CD10 expression. Cell separation tests following induction of apoptosis demonstrated that CD10+ cells were apoptotic. CD10+ cells were observed in the peripheral blood of two patients within a few hours following fludarabine infusion. In another patient, who failed to respond, no CD10+ cells were seen. Expression of CD10 was observed also in normal CD5+ B cells when these were induced into apoptosis. Interpretation and Conclusions. This study demonstrates that B-CLL cells, as well as normal CD5+ B cells, become CD10+ following apoptosis induction in vitro. Some of the data obtained also suggest a use for CD10 to monitor apoptosis of B-CLL in a clinical setting.",
keywords = "Apoptosis, Chronic lymphocytic leukemia, Fludarabine, Neutral endopeptidase",
author = "Fortunato Morabito and Massimo Mangiola and Davide Rapezzi and Simona Zupo and Oliva, {Bianca Maria} and Ferraris, {Anna Maria} and Mauro Spriano and Edoardo Rossi and Caterina Stelitano and Vincenzo Callea and Giovanna Cutrona and Manlio Ferrarini",
year = "2003",
month = "8",
day = "1",
language = "English",
volume = "88",
pages = "864--873",
journal = "Haematologica",
issn = "0390-6078",
publisher = "NLM (Medline)",
number = "8",

}

TY - JOUR

T1 - Expression of CD10 by B-chronic lymphocytic leukemia cells undergoing apoptosis in vivo and in vitro

AU - Morabito, Fortunato

AU - Mangiola, Massimo

AU - Rapezzi, Davide

AU - Zupo, Simona

AU - Oliva, Bianca Maria

AU - Ferraris, Anna Maria

AU - Spriano, Mauro

AU - Rossi, Edoardo

AU - Stelitano, Caterina

AU - Callea, Vincenzo

AU - Cutrona, Giovanna

AU - Ferrarini, Manlio

PY - 2003/8/1

Y1 - 2003/8/1

N2 - Background and Objectives. B-cell chronic lymphocytic leukemia (B-CLL) is an accumulating disease of slowly proliferating cells. CD10 is not normally expressed on the surface of B-CLL cells. The aim of this study was to ascertain whether B-CLL cells, induced into apoptosis, expressed surface CD10, since a correlation between apoptosis and CD10 expression has been demonstrated. Design and Methods. Peripheral blood cells from 31 untreated B-CLL patients were induced into apoptosis by etoposide, fludarabine or Gaμ-Ab treatment and tested for CD10 expression by flow cytometry. Normal CD5+ B cells were also induced into apoptosis and tested for CD10 expression. Results. CD10 positive cells were absent in B-CLL cell suspensions, but were detected following in vitro culture, and their appearance paralleled that of apoptotic cells. Treatment with etoposide, fludarabine or Gaμ-Ab enhanced both apoptosis and CD10 expression. Inhibition of apoptosis by VAD-fmk or Gaδ-Ab prevented CD10 expression. Cell separation tests following induction of apoptosis demonstrated that CD10+ cells were apoptotic. CD10+ cells were observed in the peripheral blood of two patients within a few hours following fludarabine infusion. In another patient, who failed to respond, no CD10+ cells were seen. Expression of CD10 was observed also in normal CD5+ B cells when these were induced into apoptosis. Interpretation and Conclusions. This study demonstrates that B-CLL cells, as well as normal CD5+ B cells, become CD10+ following apoptosis induction in vitro. Some of the data obtained also suggest a use for CD10 to monitor apoptosis of B-CLL in a clinical setting.

AB - Background and Objectives. B-cell chronic lymphocytic leukemia (B-CLL) is an accumulating disease of slowly proliferating cells. CD10 is not normally expressed on the surface of B-CLL cells. The aim of this study was to ascertain whether B-CLL cells, induced into apoptosis, expressed surface CD10, since a correlation between apoptosis and CD10 expression has been demonstrated. Design and Methods. Peripheral blood cells from 31 untreated B-CLL patients were induced into apoptosis by etoposide, fludarabine or Gaμ-Ab treatment and tested for CD10 expression by flow cytometry. Normal CD5+ B cells were also induced into apoptosis and tested for CD10 expression. Results. CD10 positive cells were absent in B-CLL cell suspensions, but were detected following in vitro culture, and their appearance paralleled that of apoptotic cells. Treatment with etoposide, fludarabine or Gaμ-Ab enhanced both apoptosis and CD10 expression. Inhibition of apoptosis by VAD-fmk or Gaδ-Ab prevented CD10 expression. Cell separation tests following induction of apoptosis demonstrated that CD10+ cells were apoptotic. CD10+ cells were observed in the peripheral blood of two patients within a few hours following fludarabine infusion. In another patient, who failed to respond, no CD10+ cells were seen. Expression of CD10 was observed also in normal CD5+ B cells when these were induced into apoptosis. Interpretation and Conclusions. This study demonstrates that B-CLL cells, as well as normal CD5+ B cells, become CD10+ following apoptosis induction in vitro. Some of the data obtained also suggest a use for CD10 to monitor apoptosis of B-CLL in a clinical setting.

KW - Apoptosis

KW - Chronic lymphocytic leukemia

KW - Fludarabine

KW - Neutral endopeptidase

UR - http://www.scopus.com/inward/record.url?scp=0141426707&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0141426707&partnerID=8YFLogxK

M3 - Article

C2 - 12935974

AN - SCOPUS:0141426707

VL - 88

SP - 864

EP - 873

JO - Haematologica

JF - Haematologica

SN - 0390-6078

IS - 8

ER -